project id: TCGA-BRCA; case submitter id: TCGA-AO-A125; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 9.5; spectrophotometer method: UV Spec; age at index: 72; days to birth: -26466; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1930; age at diagnosis: 26466; ajcc pathologic m: M0; ajcc pathologic n: N0 (i-); ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 3456.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8050/3; primary diagnosis: Papillary carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2002; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 3193; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-AO-A125-01A-11; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 4.0; percent tumor cells: 96.0; percent tumor nuclei: 96.0;